Benralizumab vs Methotrexate
Benralizumab vs Methotrexate: Overview
This comparison examines the pharmacological differences between Benralizumab and Methotrexate.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5.
Molecular Weight: Methotrexate — 454.4400 g/mol.
Type: Benralizumab — Antibody; Methotrexate — Small molecule.